InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73
United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

56
Insider
Date
Role
Action
Shares
Price
Amount
Keith Regnante
4 Nov 2023
Chief Financial Officer
Sold after exercise
40,000
$45.29
$1.81M
Keith Regnante
9 Jun 2023
Chief Financial Officer
Sold after exercise
2,579
$47.25
$121.86K
Keith Regnante
9 Jun 2023
Chief Financial Officer
Sold after exercise
1,428
$46.46
$66.34K
Keith Regnante
9 Jun 2023
Chief Financial Officer
Sold after exercise
15,993
$45.03
$720.16K
Keith Regnante
8 Jun 2023
Chief Financial Officer
Sold after exercise
2,699
$48.65
$131.31K
Keith Regnante
8 Jun 2023
Chief Financial Officer
Sold after exercise
17,301
$47.66
$824.57K
Jennifer Lachey
15 Jul 2022
Chief Scientific Officer
Sold after exercise
46,034
$30.00
$1.38M
Jennifer Lachey
13 Jul 2022
Chief Scientific Officer
Sold after exercise
1,916
$30.00
$57.48K
Jennifer Lachey
11 May 2022
Chief Scientific Officer
Sold after exercise
16
$45.45
$727.20
Jennifer Lachey
11 May 2022
Chief Scientific Officer
Sold after exercise
223
$44.23
$9.86K
Jennifer Lachey
11 May 2022
Chief Scientific Officer
Sold after exercise
719
$43.32
$31.15K
Jennifer Lachey
11 May 2022
Chief Scientific Officer
Sold after exercise
944
$42.49
$40.11K
Jennifer Lachey
11 May 2022
Chief Scientific Officer
Sold after exercise
3,398
$41.26
$140.20K
Jennifer Lachey
11 Apr 2022
Chief Scientific Officer
Sold after exercise
559
$64.15
$35.86K
Jennifer Lachey
11 Apr 2022
Chief Scientific Officer
Sold after exercise
2,315
$63.50
$147.00K
Jennifer Lachey
11 Apr 2022
Chief Scientific Officer
Sold after exercise
1,009
$62.32
$62.88K
Jennifer Lachey
11 Apr 2022
Chief Scientific Officer
Sold after exercise
1,417
$61.37
$86.96K
Christopher Rovaldi
6 Apr 2022
Chief Operating Officer
Sold after exercise
1,728
$65.00
$112.32K
Jennifer Lachey
4 Apr 2022
Chief Scientific Officer
Sold after exercise
7,950
$60.00
$477.00K
Christopher Rovaldi
1 Apr 2022
Chief Operating Officer
Sold after exercise
105
$58.83
$6.18K
Christopher Rovaldi
1 Apr 2022
Chief Operating Officer
Sold after exercise
366
$57.97
$21.22K
Christopher Rovaldi
1 Apr 2022
Chief Operating Officer
Sold after exercise
287
$56.89
$16.33K
Christopher Rovaldi
1 Apr 2022
Chief Operating Officer
Sold after exercise
104
$56.20
$5.84K
Christopher Rovaldi
1 Apr 2022
Chief Operating Officer
Sold after exercise
2
$54.34
$108.68
Jennifer Lachey
11 Mar 2022
Chief Scientific Officer
Sold after exercise
875
$54.54
$47.72K
Jennifer Lachey
11 Mar 2022
Chief Scientific Officer
Sold after exercise
713
$53.36
$38.05K
Jennifer Lachey
11 Mar 2022
Chief Scientific Officer
Sold after exercise
1,062
$52.43
$55.68K
Jennifer Lachey
11 Feb 2022
Chief Scientific Officer
Sold after exercise
199
$53.10
$10.57K
Jennifer Lachey
11 Feb 2022
Chief Scientific Officer
Sold after exercise
1,378
$52.35
$72.14K
Jennifer Lachey
11 Feb 2022
Chief Scientific Officer
Sold after exercise
1,073
$51.50
$55.26K
Jennifer Lachey
11 Jan 2022
Chief Scientific Officer
Sold after exercise
1,134
$54.45
$61.75K
Jennifer Lachey
11 Jan 2022
Chief Scientific Officer
Sold after exercise
1,196
$53.56
$64.06K
Jennifer Lachey
11 Jan 2022
Chief Scientific Officer
Sold after exercise
320
$52.01
$16.64K
Jennifer Lachey
5 Jan 2022
Chief Scientific Officer
Sold after exercise
2,650
$60.00
$159.00K
Jennifer Lachey
15 Dec 2021
Chief Scientific Officer
Sold after exercise
735
$50.00
$36.75K
Jennifer Lachey
13 Dec 2021
Chief Scientific Officer
Sold after exercise
7
$53.64
$375.48
Jennifer Lachey
13 Dec 2021
Chief Scientific Officer
Sold after exercise
390
$52.22
$20.37K
Jennifer Lachey
13 Dec 2021
Chief Scientific Officer
Sold after exercise
1,518
$50.11
$76.07K
Jennifer Lachey
11 Nov 2021
Chief Scientific Officer
Sold after exercise
4,561
$59.78
$272.66K
Jennifer Lachey
11 Nov 2021
Chief Scientific Officer
Sold after exercise
739
$58.73
$43.40K
Jennifer Lachey
10 Nov 2021
Chief Scientific Officer
Sold after exercise
15,900
$60.00
$954.00K
Jennifer Lachey
4 Nov 2021
Chief Scientific Officer
Sold after exercise
10,600
$50.00
$530.00K
Claudia Ordonez
11 Jun 2021
Chief Medical Officer
Sold after exercise
347
$51.95
$18.03K
Claudia Ordonez
11 Jun 2021
Chief Medical Officer
Sold after exercise
653
$50.48
$32.96K
Jennifer Lachey
11 Jun 2021
Chief Scientific Officer
Sold after exercise
219
$52.13
$11.42K
Jennifer Lachey
11 Jun 2021
Chief Scientific Officer
Sold after exercise
898
$51.73
$46.45K
Jennifer Lachey
11 Jun 2021
Chief Scientific Officer
Sold after exercise
1,533
$50.37
$77.22K
Jennifer Lachey
11 May 2021
Chief Scientific Officer
Sold after exercise
2,650
$50.00
$132.50K
Claudia Ordonez
11 May 2021
Chief Medical Officer
Sold after exercise
1,000
$50.15
$50.15K
Jennifer Lachey
12 Apr 2021
Chief Scientific Officer
Sold after exercise
100
$61.72
$6.17K
Jennifer Lachey
12 Apr 2021
Chief Scientific Officer
Sold after exercise
729
$61.08
$44.53K
Jennifer Lachey
12 Apr 2021
Chief Scientific Officer
Sold after exercise
3,473
$59.99
$208.35K
Jennifer Lachey
12 Apr 2021
Chief Scientific Officer
Sold after exercise
998
$59.10
$58.98K
Claudia Ordonez
12 Apr 2021
Chief Medical Officer
Sold after exercise
233
$61.23
$14.27K
Claudia Ordonez
12 Apr 2021
Chief Medical Officer
Sold after exercise
367
$60.01
$22.02K
Claudia Ordonez
12 Apr 2021
Chief Medical Officer
Sold after exercise
400
$59.09
$23.64K
Showing 250 of 403 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 174
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 72
Sales at will 274
Transactions with no price 0
Shares from compensation/vesting 18,653,788
Sales filed before the plan box existed 256
History held since 8 Apr 2020